FindTrial
Sign In

Construction of nomogram model for risk prediction of gastroesophageal reflux disease in patients with hepatitis B cirrhosis

Construction of nomogram model for risk prediction of gastroesophageal reflux disease in patients with hepatitis B cirrhosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600124283
Enrollment
Unknown
Registered
2026-05-09
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatitis B cirrhosis

Interventions

Concurrent group:None
Non-concurrent group:None

Sponsors

Pinggu District Hospital of Beijing
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Clinical diagnosis of hepatitis B cirrhosis; 2.No anti-infection treatment in the past 3 months; 3.Age >18 years old; 4.Complete clinical data;

Exclusion criteria

Exclusion criteria: 1.Those with cardiac and pulmonary insufficiency; 2.Gastrointestinal diseases such as gastrointestinal bleeding and gastrointestinal tumors; 3.Cirrhosis has developed into liver cancer patients; 4.Those with other malignant tumors; 5.Autoimmune dysfunction; 6.Obesity (BMI >=28kg/m^2), constipation, and pregnancy; 7.Gastroesophageal reflux caused by Sjogren's syndrome, hiatal hernia, or taking calcium channel blockers, diazepam and other drugs;

Design outcomes

Primary

MeasureTime frame
Occurrence of GERD ;—

Countries

China

Contacts

Public ContactLi Wei

Pinggu District Hospital of Beijing

18501151678@163.com+86 10 8999 9009

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 16, 2026